Overview

Gender

male

Theodose Melas-Kyriazi has served as a member of our board of directors since February 2017.Melas-Kyriazi has also served as Chief Financial Officer of Levitronix Technologies LLC, a biotechnology company, since 2006. From 2003 to 2016, Melas-Kyriazi served as a director at Valeant Pharmaceuticals International, Inc. He spent nearly two decades at Thermo Electron Corporation (now Thermo Fisher Scientific) in a variety of roles, including six years as Chief Financial Officer. Melas-Kyriazi has been a director of a number of private and public biopharmaceutical companies. Melas-Kyriazi received his M.B.A. from Harvard Business School.